key: cord-0753618-xbrbv798
authors: Yadav, Rahul; Pradhan, Madhulika; Yadav, Krishna; Mahalvar, Anand; Yadav, Homesh
title: Present scenarios and future prospects of herbal nanomedicine for antifungal therapy
date: 2022-05-13
journal: J Drug Deliv Sci Technol
DOI: 10.1016/j.jddst.2022.103430
sha: 422cf02b91998ea8a7102c6c250f7a733e95ebe8
doc_id: 753618
cord_uid: xbrbv798

The current COVID-19 epidemic is a sobering reminder that human susceptibility to infectious diseases remains even in our modern civilization. After all, infectious diseases are still the major reason of death globally. Healthcare authorities have often underestimated and ignored the threat posed by “microbial dangers,” although they put millions of lives at risk every year. Overlooked developing diseases including fungal infections (FIs) contribute to roughly 1.7 million fatalities per year. As many as 150 million cases of severe and potentially life-threatening FIs are reported each year. In the last few years, the number of instances has steadily increased. Most of them are invasive fungal infections that require specialized treatment and hospital care. In recent years herbal antifungal compounds have been explored to acquire effective and safe therapy against fungal infections. However, potential therapeutic effects are hampered by the poor solubility, stability, and bioavailability of these important chemicals as well as the gastric degradation that occurs in the gastrointestinal tract. To get around this issue, researchers have turned to novel drug delivery systems such as nanoemulsions, ethosomes, metallic nanoparticles, liposomes, lipid nanoparticles, transferosomes, etc by improving their limits, nanocarriers can enhance the medicinal effects of herbal oils and extracts. The present review article focuses on the available antifungal agents and their characteristics, mechanism of antifungal drugs resistance, herbal oils and extract as antifungal agents, challenges in the delivery of herbal drugs, and application of nano-drug delivery systems for effective delivery of antifungal herbal compounds.

with a high risk of treatment failure, clinical resistance is said to exist [19, 20] . Antibiotic resistance can be defined as the ability of an organism to evade typical concentrations of an antibiotic and/or to demonstrate a minimum inhibitory concentration (MIC) that falls within the range where particular mechanisms of resistance are likely and clinical benefit has not been reliably demonstrated in treatment studies [21, 22] . Fungi have adopted a variety of ways for drug resistance and the main mechanisms against azoles, echinocandins and polyenes have been discussed below in detail.

Azoles interfere with the cellular synthesis of ergosterol, a key element of the fungal cell membrane. Azole drugs prevent lanosterol 14-α-sterol-demethylase and stop the translation of lanosterol into ergosterol. As a result, the level of ergosterol in the cell membrane drops, and ultimately cellular structure and function are altered, which inhibits fungal growth [22] .

Candida species are resistant to azole antibiotics in a variety of ways. To begin with, the stimulation of efflux pumps within the fungal cell reduces drug concentration at the enzyme target, decreasing Candida's susceptibility to azole antifungals or its ability to overcome its resistance to them [23] . Azole resistance in Candida albicans and Candida dubliniensis has been linked to increased expression of efflux pumps expressed by the MDR or CDR genes. Mutations in the ERG11 encoding gene are another characteristic pathway of resistance in Candida species, resulting in a changed target with reduced affinity for or incapability to bind azoles. Candida azole resistance could also be caused by an increase in the expression or upregulation of the changed target enzyme. In some cases, this might lead to azole medicines binding poorly to certain targets [24] . The establishment of bypass routes, which negate the membrane-disrupting effects of azole medications and are associated with decreased fungal growth, is the final possible mechanism of J o u r n a l P r e -p r o o f azole resistance in Candida species. In some resistant Candida strains, the ERG3 gene has been mutated, which may explain this [25] .

Echinocandins block the manufacture of 1,3-D-glucan, a critical component of the fungal cell wall, by interfering with the function of 1,3-D-glucan synthase. As a result, yeasts develop a faulty cell wall, which can lead to cell instability and lysis, while molds develop abnormal hyphal development. Candida resistance to echinocandins has been linked to mutations in a gene that encodes components of the 1,3-D-glucan synthase complex. Point mutations in the gene encoding the main and presumed catalytic component of 1,3-D-glucan synthase have been associated with lower susceptibility or resistance of Candida to echinocandins. C krusei, C tropicalis, C glabrata, and C dubliniensis have shown this resistance mechanism [22, 26] . Echinocandin resistance in C glabrata has been linked to FKS2 gene mutations. Glucophage synthase enzyme activity is altered by FKS mutation, which results in a higher 50% inhibitory concentration (IC50) [10, 27] .

Polyenes, which include amphotericin B and nystatin, are the earliest antifungal drugs. When polyene drugs interact with fungal-specific ergosterol in the plasma membrane of fungi, they produce concentration-dependent channels that kill cells and allow ions to escape, resulting in cell death. Cells in extramembranous aggregates may be killed through the extraction of ergosterol from the lipid bilayers by amphotericin B [22, 28] [35, 36] and Euphorbia hirta L. [37] . [40] . Recently, Barros and their group reported that ethanolic extracts of stems, leaves, and rhizomes of Chamaecostus cuspidatus against Candida and Trichophyton species and reported good antifungal activity [41] .

In another study, Terças found antifungal effects in the leaf extract of Terminalia catappa when tested against Candida spp. [42] .

In vitro studies by Akroum et al. indicated that Vicia faba acetylic extract had antifungal activity against C. albicans (MIC 0.010 mg/mL). Moreover, the extract (20 g/mL) reduced mortality in mice with candidiasis after administration [43] . Todorovic et al. examined polyphenols of powders of Theobroma cacao against C. albicans. They reported good antifungal activity by the extract with a MIC of 5.0 mg/mL [44] . Numerous more plants, in addition to those listed above, are being studied for antifungal properties. Even though screening plant extracts can speed up the discovery process, research has focused on the identification of chemical components. Crude extract research may be the first stage in discovering a new promising drug, which is followed by an identification of the chemical components responsible for the antifungal action.

Essential oils (EOs) are combinations of volatile components that can be found in various plant sections (flowers, bark, leaves, fruits, and rhizomes). Steam distillation is the most common method for extracting these oils. Mono-and sesquiterpenes and phenylpropanoids are the main components of EOs, which are responsible for the plant's olfactory qualities, as well as its ability to fight off microbes [45] . EOs cause yeast cell wall damage by creating a potential gradient across the cell wall and disrupting ATP synthesis [46] . The ability of EOs to infiltrate and tear fungal cell walls and protoplasm membranes facilitates the disintegration of mitochondrial membranes. In the J o u r n a l P r e -p r o o f electron transport chain, a modification in the flow of electrons can lead to this. Cells infected with fungi may have their lipids, proteins, and supermolecules damaged as a result of this. The microbe and fungal cell walls as well as the living material membrane are destroyed by the oil elements, resulting in an overly run protoplasm and its actions [47] . The EOs have been employed for a wide variety of plant pathogens. The EOs extracted from several plants such as Allium cepa, Eugenia cariophyllata, Curcuma longa, Ocimum basilicum, Moringa olifera, Cymbopogon, Thymus vulgaris and Salvia rosmarinus have shown significant antifungal activity against a large variety of fungi [48] .

Some EOs, such as yarrow oil, pepper oil, cinnamon oil, and carrot oil, are more potent against fungi than bacteria. C. suvabenium essential oil was reported effective against Trichophyton mentagrophytes, Microsporum canis, and T. rubrum, along with C. albicans and C. glabrata with a MIC of 0.47-2.52 g/ml [49] . E. citriodora EOs from Algerian E. citriodora leaves was shown to have a stronger antifungal potential against the investigated microorganisms, with MFC ranging from (0.6 to 5L/mL and 1.25 to 5L/mL) respectively [50] . Antifungal properties of Rosmarinus officinalis EOs (REO) against A. flavus have recently been studied by da Silva and his team. MIC and MFC were both reported to be 500 g/mL. At a dosage of 250 g/mL, REO also repressed the growth of A. flavus [51] .

Maccioni and the group explored the antifungal activity of essential oil from Teucrium capitatum L. and reported that the sample significantly inhibited C. albicans [52] . Ghasemi and colleagues tested the antifungal potential of Artemisia Siebert's EOs composition against Botrytis cinerea.

When tested at concentrations of 1000 and 1500 ll-1, they found that A. Siebert's essential oil considerably slowed the test microorganism's mycelial development. They concluded that the tested essential oil has good antifungal properties [53] . Apart from the above discussed antifungal J o u r n a l P r e -p r o o f herbal extracts and EOs other antifungal herbal constituents showing effectiveness against various fungi have been elaborated in Table 1 . J o u r n a l P r e -p r o o f

To solve the shortcomings of conventional drug delivery methods, NDDS employs a revolutionary approach to drug delivery. Many unique herbal formulations have been described using proactive and plant choices, including nanocapsules, liposomal delivery systems, microsphere-based delivery systems, and ethosome-based delivery systems. The major advantages of the novel formulation over conventional formulations, include enhanced solubility, enhanced bioavailability, protection from toxicity, improved cellular distribution, constant delivery, shielding from physical and chemical breakdown, enhanced pharmacological activity, and improved stability [83] . Incorporating natural medicines into modern dose forms allows them to be administered more appropriately and effectively. Novel herbal medicine delivery systems employing liposomes, SLNs, polymeric nanoparticles, NLCs, metallic nanoparticles, etc can be developed to achieve this specifically for the treatment of fungal infections (Fig. 2 ) [84] . Various novel drug delivery systems used for encapsulating herbal extracts and EOs for antifungal treatment have been elaborated below.

J o u r n a l P r e -p r o o f Fig. 2 . Nanocarriers employed for the delivery of herbal bioactive and essential oils.

For the preservation of natural antimicrobials, liposomes are among the most widely investigated lipid-based nanostructures. Liposomes are self-assembled closed vesicular structures constituted from one or more lipid bilayers that distinguish them from the adjacent aqueous milieu [85] [86] [87] .

Liposomes have an amphiphilic character, and as a result, these structures can be utilized to encapsulate chemicals of different polarities [88, 89] . 

SLNs are nanoparticle constituted from one or more solid lipids. Their diameter ranges from 50 to 1000 nanometers, they don't require organic solvents for synthesis, they are inexpensive, and they can be easily scaled up. They are fascinating lipid-based carriers for several reasons [92] . Because of this, SLNs were created to circumvent the drawbacks of previous lipid-based nanocarriers.

Substitution of liquid oil was done with solid oil, which had an ordered crystal structure and so allowed the bioactive components to be contained inside the matrix of lipids, thereby making the emulsion more stable [93, 94] . In this regard, Lima and the group developed phytol-loaded solid lipid nanoparticles (SLN) and assessed the antifungal efficacy of the formulation against different strains of Candida species. Phytol's MIC against 15 Candida species strains was significantly improved by the encapsulating phytol inside SLN. Finally, they suggested, that the developed SLN could be an efficient cargo for phytol transport in anticandidal therapy [95] .

J o u r n a l P r e -p r o o f

NLCs are the carriers made from a mixture of solid lipids and liquid lipids, which boost loading capacity and limit bioactive ingredient ejection. [96] [97] [98] . Lipids distributed in water provide the basis of these nanostructures, which have a solid to liquid lipid ratio of 70:30. Liquid lipids in NLCs, as opposed to SLNs, prevent the particle from merging with the solid matrix, allowing bioactive substances to be encapsulated and better solubilized. NLCs, on the other hand, is created from a mixture of lipid molecules that are spatially distinct, resulting in a matrix that is more prone to encapsulating bio compounds than SLNs [99] [100] [101] . In recent research, Baldim et al.,

encapsulated Lippia sidoides essential oil (LSEO) in NLCs and examined its antifungal activity against C. auris. Both the LSEO-loaded NLC and plain LSEO showed strong activity against the yeast and did not exhibit any toxicity in the in vivo model [102] .

It's a non-intrusive vesicular carrier made up of the following components: ethanol; phospholipids;

and water. Because of the high quantity of ethanol contained in the carrier, the skin's lipid bilayer is easily disrupted by a soft, flexible carrier. Ethosomes, on the other hand, has been widely used in topical medication delivery for antifungal agents [103] . Shetty et al., developed clove oilenriched ethosomal gel and assessed its effectiveness for the treatment of cutaneous candidiasis.

Compared to pure clove oil, the ethosomal gel has acceptable antifungal efficacy against the pathogen C. albicans. Based on the results, the new formulation for clove oil administration could be a promising one for treating cutaneous candidiasis [104] .

Several active substances may be made more bioavailable through the use of a colloidal dispersion 

There has been a significant advance in the development of vesicular drug delivery systems using 

When it comes to biological applications, metallic nanocarriers have been widely tested. Because of their small size, high surface area, ability to be surface modified, and high responsiveness towards living cells, they have achieved an extraordinary position in the field of diagnosis and drug delivery. When it comes to antifungal drug delivery, silver nanoparticles (AgNPs) are a common choice [109, 110] . [113] . In another research, Karkhane and team developed Zinc oxide nanoparticles (ZnO-NPs) using aqueous extract of Sargassum vulgare (SVE) as a reducing and capping agent. The particle size of ZnO NPs ranged from 50-150 nm J o u r n a l P r e -p r o o f action against Aspergillus, Candida and saccharomyces cerevisiae (Fig. 3) . However, the antifungal activity against S. cerevisiae was found to be moderate. The results of the well-diffusion assay established highest efficacy of developed formulation on Candida and Aspergillus species [114] . as mean ± standard deviation of zone of inhibition on agar plates (Adopted from [114] ).

A polymeric nanoparticle is one in which the medicine has been dissolved, trapped, or somehow attached to the nanoparticle matrix. Nanocapsules (matrix-like structure) and nanospheres (coreshell morphology) can be formed depending on the organic phase's composition and J o u r n a l P r e -p r o o f manufacturing procedure [115] . Increasing the safety profile of these nanoparticles is their ability to transport proteins, DNA, and medications such as antifungals to cells and particular target organs in the body. Antifungal herbal ingredients have also been successfully delivered using PNPs.

In this context, Izadi and group developed Carum copticum essential oil (CEO) and Peganum harmala extract (PE) loaded chitosan nanoparticles in inprove antifungal activity against A.

alternata. The developed nanoparticles were spherical in shape having a mean size of 100 nm.

CEO-PE enriched nanoparticles presented inhibitory at a concentration of 200 ppm, while plain essential oils and extracts exhibited inhibitory concentrations at 500 and 750 ppm, respectively.

In-vivo tests demonstrated that free chitosan solution, CEO-PE, CEO, PE, also exhibited good antifungal but significantly higher activity was reported for CEO-PE enriched nanoformulation (see Fig. 4) . These results showed that CEO-PE loaded chitosan nanoparticles may successfully suppress pathogenic fungus in both in vivo and in vitro circumstances [116] .

Using an olive leaf extract-loaded chitosan nanoparticle, Muzzalupo and coworkers recently tested the antifungal effect of the nanoparticles against the fungus Fusarium proliferatum (in vitro) (AACC0215). The larger concentration of extract-loaded nanoparticles tested against the target species proved to be highly effective, according to their findings.

They found that both germination and growth were inhibited by 87.96 and 58.13 percent, respectively, according to their findings. The final thoughts were that these discoveries would allow for a reduction in the dosage of fungicides that might otherwise be detrimental to humans [117] . AgNPs were synthesized by Suwan and colleagues using an aqueous extract of Psidium guajava (PE). Poloxamer 407 polymeric micelles were used to further cover the AgNPs. Apart from the above-discussed nanocarriers, other nanocarriers used for the delivery of antifungal herbal constituents have been presented in Table 2 .

J o u r n a l P r e -p r o o f biopolymers can also be incorporated into nanocarrier formulations, as well as metals such as silver and gold, resulting in increased stability and release properties and compatibility with various delivery systems. The development of nanocarriers that can be used in conjunction with traditional methods and/or that encourage prompted antifungal release is also useful to encourage microbial protection in healthcare and other sectors, even though herbal extracts and oils have been extensively studied using nanoencapsulation. [55] K. Jassal, S. Kaushal, Rashmi, R. Rani, Antifungal potential of guava (Psidium guajava) leaves essential oil, major compounds: beta-caryophyllene and caryophyllene oxide, Arch. of an antifungal in situ nasal gel loaded with voriconazole-clove oil transferosomal nanoparticles, Drug Deliv.

COVID-19: clinical presentation and detection methods

Fungal infections in humans: the silent crisis, Microb. Cell

Invasive Fungal Infection

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision

Primary immunodeficiencies underlying fungal infections

The Changing Epidemiology of Invasive Fungal Infections

Macrophage-Associated Disorders: Pathophysiology, Treatment Challenges, and Possible Solutions

Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents

Standardization and comparative evaluation of phytochemical content and antioxidant activity of Alocasia indica and Tephrosia purpurea

The Mechanistic Targets of Antifungal Agents: An Overview

Antifungal Properties of Essential Oils and Their Compounds for Application in Skin Fungal Infections: Conventional and Nonconventional Approaches

Drug resistance in eukaryotic microorganisms

Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils

Antibacterial, Antifungal, Antimycotoxigenic, and Antioxidant Activities of Essential Oils: An Updated Review

Advances in drug delivery systems: Work in progress still needed?

Rational selection of antifungal drugs to propose a new formulation strategy to control Candida biofilm formation on venous catheters

The Future of Antifungal Drug Therapy: Novel Compounds and Targets

Design of Two Alternative Routes for the Synthesis of Naftifine and Analogues as Potential Antifungal Agents

Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance

Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

Lass-Flörl, Antifungal drug resistance among Candida species: mechanisms and clinical impact

Drug resistance and tolerance in fungi

Resistance of Candida to azoles and echinocandins worldwide

Clinical perspectives on echinocandin resistance among Candida species

Echinocandin resistance, susceptibility testing and prophylaxis: implications

Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs

Natural products--antifungal agents derived from plants

Antifungal activity in plants from Chinese traditional and folk medicine

Assessment of Euphorbia hirta L. leaf, flower, stem and root extracts for their antibacterial and antifungal activity and brine shrimp lethality

Antimicrobial activity and phytochemical characterization of Carya illinoensis

Phytochemicals and Their Antifungal Potential against Pathogenic Yeasts

Plants from Lamiaceae family as source of antifungal molecules in humane and veterinary medicine

Antifungal activity of extracts and purified saponins from the rhizomes of Chamaecostus cuspidatus against Candida and Trichophyton species

Phytochemical Characterization of Terminalia catappa Linn. Extracts and Their antifungal Activities against Candida spp

Antifungal activity of acetone extracts from Punica granatum L., Quercus suber L. and Vicia faba L

Correlation between Antimicrobial, Antioxidant Activity, and Polyphenols of Alkalized/Nonalkalized Cocoa Powders

The Essentials of Essential Oils

Chemical composition of 8 eucalyptus species' essential oils and the evaluation of their antibacterial, antifungal and antiviral activities

A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens

Antifungal effect of plant extract and essential oil

Antibacterial and antifungal properties of essential oils

Essential oil of Algerian Eucalyptus citriodora: Chemical composition, antifungal activity

Antifungal and antiaflatoxigenic activity of rosemary essential oil

Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus

Chemical composition, toxicity and larvicidal and antifungal activities of Persea americana (avocado) seed extracts

Chemical composition and antifungal activity of essential oils from medicinal plants of Kazakhstan

Antibacterial and antifungal activities of pyroligneous acid from wood of Eucalyptus urograndis and Mimosa tenuiflora

Tithoniamarin and tithoniamide: a structurally unique isocoumarin dimer and a new ceramide from Tithonia diversifolia

Antifungal sesquiterpene from the root of Vernonanthura tweedieana

Antifungal and antimycotoxigenic effects of Zingiber officinale, Cinnamomum zeylanicum and

Cymbopogon martinii essential oils against Fusarium verticillioides

In Vitro Antibacterial and Antifungal Potential of Amyrin-Type Triterpenoid Isolated from Datura metel Linnaeus

Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi

Antifungal activity of Rubia tinctorum, Rhamnus frangula and Caloplaca cerina

Chitin synthase 2 inhibitory activity of O-methyl pisiferic acid and 8

Medicinal Plants Having Antifungal Properties

Trypanocidal and antifungal activities of p-hydroxyacetophenone derivatives from Calea uniflora (Heliantheae, Asteraceae)

Chemical characterization, antiproliferative and antifungal activities of Clinacanthus nutans

The antifungal activity and mechanisms of action of quantified extracts from berries, leaves and roots of Phytolacca tetramera

Antifungal efficacy of Thevetia peruviana leaf extract against Alternaria solani and characterization of novel inhibitory compounds by Gas Chromatography-Mass Spectrometry analysis

Antifungal Activity of Phenolic and Polyphenolic Compounds from Different Matrices of Vitis vinifera L. against Human Pathogens

Antifungal activity and mechanism of action of Ou-gon (Scutellaria root extract) components against pathogenic J o u r n a l P r e -p r o o f fungi

Unusual Flavones from Primula macrocalyx as Inhibitors of OAT1 and OAT3 and as Antifungal Agents against Candida rugosa

Plant extracts: from encapsulation to application

Potential of Neoteric Phytoactives and Herbs for Targeting Pathophysiological Modules of Arthritis

Commercial aspects and market potential of novel delivery systems for bioactives and biological agents

Challenges and need of delivery carriers for bioactives and biological agents: an introduction

Promising Phytoactives Candidates for Efficacious Treatment of Psoriasis and Other Skin Disorders

Novel Drug Delivery Systems for Loading of Natural Plant Extracts and Their Biomedical Applications

Importance of novel drug delivery systems in herbal medicines

Colloidal and vesicular delivery system for herbal bioactive constituents

Nanovesicles delivery approach for targeting steroid mediated mechanism of antipsoriatic therapeutics

Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis

Nano Phytomedicine Based Delivery System for CNS Disease

Herbal Drugs and Natural Products in the light of Nanotechnology and Nanomedicine for Developing Drug Formulations

Herbal liposome for the topical delivery of ketoconazole for the effective treatment of seborrheic dermatitis

Curcumin Encapsulated PEGylated Nanoliposomes: A Potential Anti-Infective Therapeutic Agent

Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation

Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil

Development and characterization of corticosteroid loaded lipid carrier system for psoriasis, Res

Phytol-Loaded Solid Lipid Nanoparticles as a Novel Anticandidal

Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment

Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis

Topical delivery of fluocinolone acetonide integrated NLCs and salicylic acid enriched gel: A potential and synergistic approach in the management of psoriasis

Synergism of plant extract and vegetable oils-based lipid nanocarriers: Emerging trends in development of advanced cosmetic prototype products

Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies

A method of preparation of

Triamcinolone Acetonide encapsulated nanostructured lipid carriers for psoriasis treatment

Lippia sidoides essential oil encapsulated in lipid nanosystem as an anti-Candida agent

Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases

Novel ethosomal gel of clove oil for the treatment of cutaneous candidiasis

Nanoemulsion: Concepts, development and applications in drug delivery

Nanoemulsion Formulation of Ocimum gratissimum Essential Oil and Its Antifungal Activity Against Penicillium digitatum

Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics

Targeting autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches

Green synthesis of silver nanoparticles using Zingiber officinale and Thymus vulgaris extracts: characterisation, cell cytotoxicity, and its antifungal activity against Candida albicans in comparison to fluconazole

Green Silver Nanoparticles Formed by Phyllanthus urinaria, Pouzolzia zeylanica, and Scoparia dulcis Leaf Extracts and the Antifungal Activity

Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species

Antifungal, antioxidant and photocatalytic activities of zinc nanoparticles synthesized by Sargassum vulgare extract

Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies

Antifungal activity of hydrocolloid nano encapsulated Carum copticum essential oil and Peganum harmala extract on the pathogenic fungi Alternaria alternata

Antifungal activity of polymeric micelles of silver nanoparticles prepared from Psidium guajava aqueous extract

Antifungal properties of phosphatidylcholineoleic acid liposomes encapsulating garlic against environmental fungal in wheat bread

Preparation and characterization of liposomes containing essential oil of Eucalyptus camaldulensis leaf

Artemisia annua essential oil extraction, characterization, and incorporation in nanoliposomes, smart drug delivery systems against Candida species

Antifungal activity of Zataria multiflora essential oil-loaded solid lipid nanoparticles in-vitro condition

Solid lipid nanoparticles containing copaiba oil and allantoin: development and role of nanoencapsulation on the antifungal activity

Design of Nanostructured Lipid Carriers Containing

Effect of Cinnamon Essential Oil-Loaded Nanostructured Lipid Carriers (NLC) Against Penicillium Citrinum and Penicillium Expansum

Tangerine Decay

Augmented photocatalytic, antibacterial and antifungal activity of prunosynthetic silver nanoparticles

Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen

Lawsonia inermismediated synthesis of silver nanoparticles: activity against human pathogenic fungi and bacteria with special reference to formulation of an antimicrobial nanogel

Rapid biosynthesis and characterization of silver nanoparticles from the leaf extract of Tropaeolum majus L. and its enhanced in-vitro antibacterial, antifungal, antioxidant and anticancer properties

Green synthesis using green and black tea leaves extracts and evaluation of antibacterial, antifungal and aflatoxin B1 adsorption activity

Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles